UNILORIN Partners University of Wisconsin- Madison, U.S On Stem Cell Research

Started by femifemzy3, Jan 28, 2014, 01:07 PM

femifemzy3

Prof. AbdulGaniyu Ambali, the Vice Chancellor of the University of Ilorin, said the institution was collaborating with the University of Wisconsin- Madison, U.S. on stem cell research.
.
This is contained in a statement signed by Mr Kunle Akogun, the Director, Corporate Affairs Unit of the University on Monday in Ilorin.
.
The statement said the vice chancellor was a one week visit to the University of Wisconsin- Madison, U.S.
.
It said that the collaboration with Wisconsin- Madison would afford the University a world class Stem Cell Research Laboratory.
.
It said Ambali visited the Chancellor of the University of Wisconsin-Madison, Prof. Rebecca Blank, and some world renowned experts on Stem Cell Research, including Prof. Su-Chun Zhang.
.
"The VC also met with other renowned stem cell researchers; Prof. Ralph Albrecht, Prof. Jeff Johnson and Prof. Tim Kamp," it said.
.
"The VC had successfully secured commitment from the University of Wisconsin-Madison to partner UNILORIN and the university would ensure the structural development of the stem cell research centre.
.
"The VC had stressed the commitment of the University to the training of technical staff on stem cell research and related activities," it said.
.
The statement noted that the University of Ilorin would be responsible for the provision of relevant regulations to support the development of the stem cell research centre.
.
It added that the university would also provide security and accommodation for all visiting staff of the University of Wisconsin-Madison after they arrived in Nigeria.
.
It noted that Ambali's visit was in furtherance of the Federal Government's mandate to the University as the only University designated in the North-central geopolitical zone for Bio- Technology research.
.
"The VC reiterated the resolve of the University to produce a critical mass of health professionals with competencies in management and control of common communicable and non- communicable diseases.
.
"We also want to translate research findings and generate funds through the commercialisation of key research outputs and foster national, regional and international linkages for collaborative research in partnership,'' it said.